KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Net Margin (2016 - 2025)

Medpace Holdings' Net Margin history spans 11 years, with the latest figure at 19.07% for Q4 2025.

  • For Q4 2025, Net Margin fell 273.0% year-over-year to 19.07%; the TTM value through Dec 2025 reached 17.83%, down 134.0%, while the annual FY2025 figure was 17.83%, 134.0% down from the prior year.
  • Net Margin reached 19.07% in Q4 2025 per MEDP's latest filing, up from 16.84% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 21.81% in Q4 2024 to a low of 13.25% in Q2 2023.
  • Average Net Margin over 5 years is 16.95%, with a median of 16.76% recorded in 2023.
  • Peak YoY movement for Net Margin: tumbled -337bps in 2021, then soared 610bps in 2024.
  • A 5-year view of Net Margin shows it stood at 16.22% in 2021, then rose by 7bps to 17.42% in 2022, then decreased by -10bps to 15.71% in 2023, then surged by 39bps to 21.81% in 2024, then fell by -13bps to 19.07% in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Net Margin are 19.07% (Q4 2025), 16.84% (Q3 2025), and 14.96% (Q2 2025).